Effect of Vitamin E on Blood Pressure of Hemodialysis Patients

Phase 2

Recruiting

• Conditions: Chronic Kidney Disease.; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20090701002113N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Hemodialysis Patients
18-70 years old
Shiraz University of Medical Sciences HD center
Maintenance HD at least for 3 months

Exclusion Criteria

Smoking and alcohol consumer
Anti-oxidant supplements use
Liver or Heart Failure
Diabetes mellitus
Obstructive uropathy
Endocrine cancers
Hemoglobine <9 mg/dL
Coronary vessels disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood Pressure (systolic and diastolic). Timepoint: Before the intervention, the beginning of the intervention (the first day), the end of each week after the intervention and the end of the intervention (the end of the eighth week). Method of measurement: Measure blood pressure using sphygmomonometer.

Secondary Outcome Measures

Name	Time	Method
Effect of vitamin E on serum creatinine. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Jaffe method - Autoanalyzer.;Effect of vitamin E on hemoglobine. Timepoint: Before and after 8 weeks of intervention. Method of measurement: cyanmethemoglobin method (CM)- Spectrophotometric method.